Changing trends in cardiovascular risk factors among adults in southern Nigeria

Chibuike E. Nwafor; Julius Edeogu; Stanley O. Rosemary; Blessing Chinaza Enyichukwu; Jovita Agbamoro

doi:10.18203/2320-6012.ijrms20240505

Authors

Chibuike E. Nwafor Department of Medicine, University of Port Harcourt and University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers, Nigeria
Julius Edeogu Department of Medicine, University of Port Harcourt and University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers, Nigeria
Stanley O. Rosemary Department of Medicine, University of Port Harcourt and University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers, Nigeria
Blessing Chinaza Enyichukwu GoodHeart Medical Consultants, Port Harcourt, Rivers, Nigeria
Jovita Agbamoro GoodHeart Medical Consultants

DOI:

https://doi.org/10.18203/2320-6012.ijrms20240505

Keywords:

Cardiac centre, Cardiovascular diseases, Diabetes mellitus, Dyslipidemia

Abstract

Background: Globally, cardiovascular diseases (CVDs) cause 17.9 million deaths yearly. In nations like Nigeria, diabetes, hypertension, and obesity, coupled with modifiable behaviors such as physical inactivity, unhealthy diet, smoking, and alcohol use, are rising. This study focused on assessing the evolving prevalence and distribution of CVD risk factors among adults in southern Nigeria.

Methods: This cross-sectional study, conducted in Port Harcourt, Rivers state, was part of world heart day celebrations over three years (September 2019-September 2023). 309 adults participated, undergoing screening for blood pressure, fasting blood glucose, lipid profile, and body mass index calculated from weight and height measurements.

Results: Over three years, 309 subjects (mean age 46.63±12.03) were studied, with 53.40% females and 46.28% males. Most cardiovascular risk factors occurred in the 41-50 age group. Hypertension rose from 65.63% (2019) to 75.29% (2023), dipping to 64.79% (2022). Obesity decreased from 29.69% (2019) to 24.71% (2023), rising to 30.99% (2022). Diabetes increased from 23.44% (2019) to 27.59% (2023), decreasing to 19.71% (2022). Total cholesterol rose from 1.56% (2019) to 2.9% (2023). High LDL increased from 3.12% (2019) to 12.7% (2023). Low HDL and high TRIG decreased from 2019 to 2023.

Conclusions: From 2019 to 2023, cardiovascular risk factors like hypertension, obesity, diabetes, and dyslipidemia increased, with a slight fluctuation in 2022. Heightened awareness and preventive measures against adult CVD risk factors are imperative. National education on risk factors is vital for individuals to monitor their blood pressure, weight, cholesterol, and blood sugar levels.

Metrics

Metrics Loading ...

References

World Health Organization. Global status report on noncommunicable diseases 2010. 2011. Available from: https://iris.who.int/handle/10665/44579. Accessed on 15 December 2023.

Mc Namara K, Alzubaidi H, Jackson JK. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr Pharm Res Pract. 2019;8:1-11.

Kelly BB, Fuster V, eds. Epidemiology of Cardiovascular Disease. In: Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. National Academies Press (US); 2010

Oguoma VM, Nwose EU, Skinner TC, Digban KA, Onyia IC, Richards RS. Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to CVD risks screening. BMC Public Health. 2015;15(1):397.

Oluyombo R, Olamoyegun MA, Olaifa O, Iwuala SO, Babatunde OA. Cardiovascular risk factors in semi-urban communities in southwest Nigeria: Patterns and prevalence. JEGH. 2014;5(2):167.

Oguanobi NI, Ejim EC, Onwubere BJ, Ike SO, Anisiuba BC, Ikeh VO, et al. Pattern of cardiovascular disease amongst medical admissions in a regional teaching hospital in Southeastern Nigeria. Niger J Cardiol. 2013;10(2):77.

Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, Levin-Rector A, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2071-94.

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-60.

Sani MU, Adamu B, Mijinyawa MS, Abdu A, Karaye KM, Maiyaki MB, et al. Ischaemic heart disease in Aminu Kano Teaching Hospital, Kano, Nigeria: a 5-year review. Niger J Med. 2006;15(2):128-31.

Eze CO, Kalu UA, Nnaji T. Cardiovascular risk factors in south-eastern Nigeria: a community based survey. WJCD. 2020;10(07):417-24.

Daviglus ML, Talavera GA, Avilés-Santa ML, Allison M, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308(17):1775.

Ude C. Towards a legal framework for the introduction of smart cities as a solution to energy poverty and carbon emissions in Nigeria. University of Nigeria. 2023.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314-40.

Familoni OB, Odusan O, Raimi TH. The relationship between QT intervals and cardiac autonomic neuropathy in Nigerian patients with type 2 diabetes mellitus. Niger Med Pract. 2008;53(4):48-51.

Dahiru T, Ejembi CL. Clustering of cardiovascular disease risk‑factors in semi‑urban population in Northern Nigeria. Niger J Clin Pract. 2013;16(4).

National Cholesterol Education Program (US). Expert Panel on Detection, Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). The Program; 2002.

Wong KLM, Radovich E, Owolabi OO, Campbell OMR, Brady OJ, Lynch CA, et al. Why not? Understanding the spatial clustering of private facility-based delivery and financial reasons for homebirths in Nigeria. BMC Health Serv Res. 2018;18(1):397.

Onyemelukwe GC, Ogunfowokan O, Mbakwem A, Alao AK, Soroh K, Omorodion O, et al. Cardiovascular risk factors in adult general out-patient clinics in Nigeria: a country analysis of the Africa and Middle East Cardiovascular Epidemiological (ACE) study. Afr Health Sci. 2017;17(4):1070-81.

Ejim EC, Okafor CI, Emehel A, Mbah AU, Onyia U, Egwuonwu T, et al. Prevalence of cardiovascular risk factors in the middle-aged and elderly population of a Nigerian rural community. J Trop Med. 2011;2011:1-6.

Ekanem US, Opara DC, Akwaowo CD. High blood pressure in a semi-urban community in south-south Nigeria: a community-based study. Afr Health Sci. 2013;13(1):56-61.

Oyeyemi AL, Adeyemi O. Relationship of physical activity to cardiovascular risk factors in an urban population of Nigerian adults. Arch Public Health. 2013;71(1):6.

Mogas SB, Tesfaye T, Zewde B, Tesfaye Y, Kebede A, Tadesse M, et al. Burden of undiagnosed hypertension among adults in urban communities of southwest Ethiopia. Integr Blood Press Control. 2021;14:69-76.

Afolabi WAO, Addo AA, Sonibare MA. Activity pattern, energy intake and obesity among Nigerian urban market women. Int J Food Sci Nutr. 2004;55(2):85-90.

Kruger HS, Venter CS, Vorster HH, Margetts BM. Physical inactivity is the major determinant of obesity in black women in the north west province, South Africa: the THUSA study. Nutrition. 2002;18(5):422-7.

Alberts M, Urdal P, Steyn K, Stensvold I, Tverdal A, Nel JH, et al. Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovasc Prevent Rehabil. 2005;12(4):347-54.

Bello-Sani F, Bakari AG, Anumah FE. Dyslipidaemia in persons with type 2 diabetes mellitus in Kaduna, Nigeria. Dubai Diabetes Endocrinol J. 2007;15(1):9-13.

Isezuo SA, Badung SLH, Omotoso ABO. Comparative analysis of lipid profiles among patients with type 2 diabetes mellitus, hypertension and concurrent type 2 diabetes, and hypertension: a view of metabolic syndrome. J Nat Med Assoc. 2003;95(5):328.

Adamu U, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae A. Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension. VHRM. 2013;763.

Odenigbo CU, Oguejiofor OC, Odenigbo UM, Ibeh CC, Ajaero CN, Odike MA. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria. Niger J Clin Pract. 2008;11(4).

Akubudike Alikor C, Emem-Chioma P. Clustering of cardiovascular disease risk factors in a rural adult population in Nigeria. Int J Res Med Sci. 2018;6(3):765.

Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol. 2012;60(14):1207-16.